Axonics Inc AXNX Stock Analysis
- Nasdaq
- Stock
- Market open · no trades yet today
$1.03 up $0.04, 4.20% at close Nov 5
Last close · Previous close $0.99
- Market cap
- $1.03MAt the Nov 5 close
- Dividend yield
- NoneLast 12 months
Price chart
$1.03up $0.04, 4.20%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.99Nov 4
- Volume48.33KNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume499.73KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.68 to $2.11; now $1.03
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
AXNX trailed the S&P 500 in both periods.
| Period | AXNX and S&P 500 | vs S&P 500 |
|---|---|---|
| Long term | ||
| 3Y | AXNX: down 99.2% S&P 500: up 74.8% −80.4% vs +20.5% a year | AXNX trailed the S&P 500 by 174.0 percentage points Trailed |
| 5Y | AXNX: down 99.4% S&P 500: up 67.3% −64.0% vs +10.8% a year | AXNX trailed the S&P 500 by 166.7 percentage points Trailed |
$10,000 invested in AXNX 5 years ago (Nov 5, 2021) would be worth about $61 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,730.
AXNX trailed the S&P 500 in both periods.
| Period | AXNX and S&P 500 | vs S&P 500 |
|---|---|---|
| Long term | ||
| 3Y | AXNX: down 99.2% S&P 500: up 68.6% −80.4% vs +19.0% a year | AXNX trailed the S&P 500 by 167.8 percentage points Trailed |
| 5Y | AXNX: down 99.4% S&P 500: up 56.4% −64.0% vs +9.4% a year | AXNX trailed the S&P 500 by 155.8 percentage points Trailed |
$10,000 invested in AXNX 5 years ago (Nov 5, 2021) would be worth about $61 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,645.
All-time high
$196.65
Closing high on . Now 99.5% below that record.
Split-adjusted daily closes since Oct 31, 2018.
Stock splits
1
2-for-5 on . Share counts adjust after each split.
Valuation
The Nov 5 close compared with reported results. 12-month figures aren’t available until four quarters are reported. Tap a metric to see how it’s calculated. Per-share results and the measures based on them are paused. See the note under the price.
Price-to-earnings (P/E)
Not available
12-month figures aren’t available until four quarters are reported.
Other valuation measures
- Price-to-bookPausedBook value as of Mar 31, 2026
See the note under the price. - $1.15MAt the Nov 5 close
What it would cost to buy the whole business: the market cap at the Nov 5 close, plus debt, minus cash and short-term investments from the Mar 31, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own AXNX DCF in Excel. Value Axonics with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q4 FY26, the quarter ended Mar 31, 2026, and balance-sheet figures are as of Mar 31, 2026. 12-month figures aren’t available until four quarters are reported.
Revenue and net income
12-month figures aren’t available until four quarters are reported.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY23 (Mar 31, 2023) | Not reported | Not reported | Paused See the note under the price. |
| Q4 FY24 (Mar 31, 2024) | Not reported | Not reported | Paused See the note under the price. |
| Q2 FY25 (Sep 30, 2024) | Not reported | Not reported | Paused See the note under the price. |
| Q4 FY25 (Mar 31, 2025) | Not reported | Not reported | Paused See the note under the price. |
| Q2 FY26 (Sep 30, 2025) | Not reported | Not reported | Paused See the note under the price. |
| Q4 FY26 (Mar 31, 2026) | Not reported | Not reported | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY23 (Mar 31, 2023) | $2.67M | $819.42K | Paused See the note under the price. |
| FY24 (Mar 31, 2024) | $4.38M | $783.44K | Paused See the note under the price. |
| FY25 (Mar 31, 2025) | $3.27M | −$1.46M | Paused See the note under the price. |
| FY26 (Mar 31, 2026) | $2.29M | −$10.31M | Paused See the note under the price. |
Margins
- Gross
- Operating
- Net
The lines show each quarter. What margins tell you
Cash flow
12-month figures aren’t available until four quarters are reported.
Shareholder returns
12-month figures aren’t available until four quarters are reported.
Balance sheet
- $3.46MAs of Mar 31, 2026
Cash plus short- and long-term marketable securities on the Mar 31, 2026 balance sheet.
- Total debt$1.08MAs of Mar 31, 2026
- Net cash$2.38MAs of Mar 31, 2026
- Book value per sharePausedAs of Mar 31, 2026
See the note under the price. - 1.89As of Mar 31, 2026
Current assets divided by current liabilities on the Mar 31, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.33As of Mar 31, 2026
Total debt divided by shareholders’ equity on the Mar 31, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
12-month figures aren’t available until four quarters are reported.
About Axonics Inc
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction.
- Sector
- Industrials
- Industry
- Engineering & Construction
- Headquarters
- Hong Kong
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
AXNX news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
AXNX stock FAQ
What is AXNX stock’s price today?
Axonics (AXNX) traded at $1.03 at the close on , up $0.04 (4.20%) from the previous close of $0.99. Over the past 52 weeks it has traded between $0.68 and $2.11.
If you invested $1,000 in AXNX 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in AXNX on would be worth about $6 at the close on , a total return of −99.4%. Past performance doesn’t predict future returns.
What is Axonics’s market cap?
Axonics’s market capitalization is about $1.0 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $1.03 (how market cap works).
Does AXNX pay a dividend?
Axonics hasn’t paid a dividend in the last twelve months.
What is AXNX’s 52-week high and low?
Over the past 52 weeks AXNX has traded as low as $0.68 and as high as $2.11. At $1.03 at the close on , it is 51.2% below that high and 51.5% above the low.
What is AXNX’s all-time high?
AXNX’s highest closing price was $196.65 on , adjusted for stock splits. At $1.03 at the close on , it is 99.5% below that record.
Has AXNX stock ever split?
Yes, once: 2-for-5 on .
What sector and industry is Axonics in?
Axonics is in the Industrials sector and the Engineering & Construction industry, and is headquartered in Hong Kong.
What exchange does AXNX trade on?
Axonics trades on the Nasdaq under the ticker symbol AXNX. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.